<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbh="https://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/elements/1.1/" xmlns:ns2="http://purl.org/dc/terms/" xmlns:ns3="http://purl.obolibrary.org/obo/">
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_1_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_1_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb6b00392_1_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:elements>gccgccaccatggagacagacacactcctgctatgggtgctgctgctctgggttccaggttccacaggtcaccaccatcaccatcacgacgacgacgacaagatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_2_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb6b00392_2_sequence</sbol:displayId>
    <sbol:elements>gccgccaccatggagacagacacactcctgctatgggtgctgctgctctgggttccaggttccacaggtcaccaccatcaccatcacgacgacgacgacaagatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagatcaagaaaactagcttcaagggagatgccggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_2_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_4_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_4_sequence/1"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_4_comp"/>
    <sbol:displayId>sb6b00392_4_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_12_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_12_sequence/1"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_12_comp"/>
    <sbol:displayId>sb6b00392_12_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_1_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00392_1_comp</sbol:displayId>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_1_sequence/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_1_comp"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_8_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00392_8_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_8_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagatcaagaaaactagcttcaagggagatgccggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_7_sequence/1">
    <sbol:elements>gccgccaccatgcagcccatcctgctccttctggccttcctgctgctgcccagggccgacgccatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggg</sbol:elements>
    <sbol:displayId>sb6b00392_7_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_7_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_5_sequence/1">
    <sbol:displayId>sb6b00392_5_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gccgccaccatggagacagacacactcctgctatgggtgctgctgctctgggttccaggttccacaggtcaccaccatcaccatcacgaaaacctgtacttccaaatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_5_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_8_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_8_comp"/>
    <sbol:displayId>sb6b00392_8_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_8_sequence/1"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_2_comp/1">
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_2_comp"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:displayId>sb6b00392_2_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_2_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_9_comp/1">
    <sbol:displayId>sb6b00392_9_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_9_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_9_comp"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_4_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>taagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_4_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00392_4_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_12_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00392_12_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_12_sequence"/>
    <sbol:elements>gccgccaccatgcagcccatcctgctccttctggccttcctgctgctgcccagggccgacgccggggagatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctacgggggtggtgggagcatggtgagcaagggcgaggaggataacatggccatcatcaaggagttcatgcgcttcaaggtgcacatggagggctccgtgaacggccacgagttcgagatcgagggcgagggcgagggccgcccctacgagggcacccagaccgccaagctgaaggtgaccaagggtggccccctgcccttcgcctgggacatcctgtcccctcagttcatgtacggctccaaggcctacgtgaagcaccccgccgacatccccgactacttgaagctgtccttccccgagggcttcaagtgggagcgcgtgatgaacttcgaggacggcggcgtggtgaccgtgacccaggactcctccttgcaggacggcgagttcatctacaaggtgaagctgcgcggcaccaacttcccctccgacggccccgtaatgcagaagaagaccatgggctgggaggcctcctccgagcggatgtaccccgaggacggcgccctgaagggcgagatcaagcagaggctgaagctgaaggacggcggccactacgacgctgaggtcaagaccacctacaaggccaagaagcccgtgcagctacccggcgcctacaacgtcaacatcaagttggacatcacctcccacaacgaggactacaccatcgtggaacagtacgaacgcgccgagggccgccactccaccggcggcatggacgagctgtacaagtaa</sbol:elements>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_3_sequence/1">
    <sbol:elements>gccgccaccatggagacagacacactcctgctatgggtgctgctgctctgggttccaggttccacaggtcaccaccatcaccatcactccgatcaggaggccaaaccatcaaccgaagatctcggggacaagaaagagggcgaatatatcaagcttaaggtgattggccaagatagtagcgaaattcacttcaaagtgaaaatgaccactcacctgaagaaactgaaagagtcctactgtcagcgacagggcgtgccaatgaacagcctgagatttctgttcgagggacagcgaatcgctgataaccacacacctaaggaactcggaatggaagaagaggatgtaatagaggtttaccaggaacagaccggagggatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_3_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00392_3_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_9_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_9_sequence"/>
    <sbol:displayId>sb6b00392_9_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gccgccaccatgcagcccatcctgctccttctggccttcctgctgctgcccagggccgacgcctccgatcaggaggccaaaccatcaaccgaagatctcggggacaagaaagagggcgaatatatcaagcttaaggtgattggccaagatagtagcgaaattcacttcaaagtgaaaatgaccactcacctgaagaaactgaaagagtcctactgtcagcgacagggcgtgccaatgaacagcctgagatttctgttcgagggacagcgaatcgctgataaccacacacctaaggaactcggaatggaagaagaggatgtaatagaggtttaccaggaacagaccggagggatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_7_comp/1">
    <sbol:displayId>sb6b00392_7_comp</sbol:displayId>
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_7_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_7_comp"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_5_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_5_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb6b00392_5_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_5_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_11_comp/1">
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_11_sequence/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_11_comp"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb6b00392_11_comp</sbol:displayId>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_6_comp/1">
    <sbol:displayId>sb6b00392_6_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_6_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_6_comp"/>
    <sbol:version>1</sbol:version>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_10_comp/1">
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_10_comp"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb6b00392_10_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_10_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00392_3_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_3_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00392_3_sequence/1"/>
    <sbol:version>1</sbol:version>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <sbol:displayId>sb6b00392_3_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_11_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:elements>tggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:displayId>sb6b00392_11_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_11_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:Collection rdf:about="http://examples.org/sb6b00392/1">
    <ns1:subject>HER2</ns1:subject>
    <ns1:subject>peptide</ns1:subject>
    <ns2:references>Kintzing, J. R., Filsinger Interrante, M. V., Cochran, J. R. Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment Trends Pharmacol. Sci. 2016. 37:993-1008.</ns2:references>
    <ns1:subject>SUMO1</ns1:subject>
    <ns2:dateAccepted>2017-05-16</ns2:dateAccepted>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_2_sequence/1"/>
    <ns1:subject>tetrapeptide</ns1:subject>
    <ns1:subject>MCF7</ns1:subject>
    <ns1:subject>Jurkat</ns1:subject>
    <ns1:subject>sentrin-specific protease 1</ns1:subject>
    <ns1:subject>woodchuck</ns1:subject>
    <ns1:subject>gated Raji target cells</ns1:subject>
    <ns1:subject>CatC</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_10_comp/1"/>
    <ns2:references>Dang, C. V. MYC on the path to cancer Cell 2012. 149:22-35.</ns2:references>
    <ns2:references>Li, T., Huang, S., Dong, M., Gui, Y., Wu, D. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy Urol. Oncol. 2013. 31:1539-45.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_9_sequence/1"/>
    <ns1:subject>Ni-NTA</ns1:subject>
    <ns1:subject>Fluo-4</ns1:subject>
    <ns1:subject>Gly-Glu dipeptide</ns1:subject>
    <ns1:subject>PEI</ns1:subject>
    <ns2:references>Kranenburg, O. The KRAS oncogene: past, present, and future Biochim. Biophys. Acta, Rev. Cancer 2005. 1756:81-2.</ns2:references>
    <ns0:wasDerivedFrom rdf:resource="https://pubs.acs.org/doi/10.1021/acssynbio.6b00392"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_10_sequence/1"/>
    <ns1:publisher>American Chemical
Society</ns1:publisher>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_5_sequence/1"/>
    <ns1:subject>ClaI</ns1:subject>
    <ns2:references>Rotonda, J., Garcia-Calvo, M., Bull, H. G., Geissler, W. M., McKeever, B. M., Willoughby, C. A., Thornberry, N. A., Becker, J. W. The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1 Chem. Biol. 2001. 8:357-68.</ns2:references>
    <ns1:subject>Protease</ns1:subject>
    <ns2:references>Bortner, C. D., Cidlowski, J. A. A necessary role for cell shrinkage in apoptosis Biochem. Pharmacol. 1998. 56:1549-1559.</ns2:references>
    <ns1:subject>IL-2</ns1:subject>
    <ns1:subject>peroxidase</ns1:subject>
    <ns1:subject>peptides</ns1:subject>
    <ns1:subject>mouse</ns1:subject>
    <ns2:title>Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity</ns2:title>
    <ns2:references>Hinrichs, C. S., Restifo, N. P. Reassessing target antigens for adoptive T-cell therapy Nat. Biotechnol. 2013. 31:999-1008.</ns2:references>
    <ns1:subject>SUMO-GrB</ns1:subject>
    <ns1:subject>rhEGF</ns1:subject>
    <ns2:references>Zah, E., Lin, M.-Y., Silva-Benedict, A., Jensen, M. C., Chen, Y. Y. T cells expressing CD19/CD20 bi-specific chimeric antigen receptors prevent antigen escape by malignant B cells Cancer Immunol. Res. 2016. 4:498-508.</ns2:references>
    <ns1:subject>FITC</ns1:subject>
    <ns2:references>Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., Hughes, M. S., Kammula, U. S., Phan, G. Q., Lim, R. M., Wank, S. A., Restifo, N. P., Robbins, P. F., Laurencot, C. M., Rosenberg, S. A. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis Mol. Ther. 2011. 19:620-6.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_6_sequence/1"/>
    <ns1:subject>DRAQ7</ns1:subject>
    <ns1:subject>Jurkat T cells</ns1:subject>
    <ns2:references>Bailey, D., O&#8217;Hare, P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1 J. Biol. Chem. 2004. 279:692-703.</ns2:references>
    <ns1:subject>Pfn</ns1:subject>
    <ns1:subject>CD8</ns1:subject>
    <ns1:subject>IEPD</ns1:subject>
    <ns1:subject>Jurkat cells</ns1:subject>
    <ns2:references>Bernard, P. S., Wittwer, C. T. Real-Time PCR Technology for Cancer Diagnostics Clin. Chem. 2002. 48:1178-1185.</ns2:references>
    <ns1:subject>DDDDK</ns1:subject>
    <ns1:subject>IRES</ns1:subject>
    <ns1:subject>serine proteases</ns1:subject>
    <ns2:references>Kochenderfer, J. N., Dudley, M. E., Kassim, S. H., Somerville, R. P. T., Carpenter, R. O., Stetler-Stevenson, M., Yang, J. C., Phan, G. Q., Hughes, M. S., Sherry, R. M., Raffeld, M., Feldman, S., Lu, L., Li, Y. F., Ngo, L. T., Goy, A., Feldman, T., Spaner, D. E., Wang, M. L., Chen, C. C., Kranick, S. M., Nath, A., Nathan, D.-A. N., Morton, K. E., Toomey, M. A., Rosenberg, S. A. Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor J. Clin. Oncol. 2015. 33:540-549.</ns2:references>
    <ns2:references>Denmeade, S. R., Isaacs, J. T. Engineering enzymatically activated &#8220;molecular grenades&#8221; for cancer Oncotarget 2012. 3:666-7.</ns2:references>
    <ns2:references>Flotho, A., Melchior, F. Sumoylation: A Regulatory Protein Modification in Health and Disease Annu. Rev. Biochem. 2013. 82:357-385.</ns2:references>
    <ns1:subject>COVERT</ns1:subject>
    <ns1:subject>RWPE-1 cells</ns1:subject>
    <ns1:subject>EK</ns1:subject>
    <ns2:references>Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., Qu, J., Wasielewska, T., He, Q., Fink, M., Shinglot, H., Youssif, M., Satter, M., Wang, Y., Hosey, J., Quintanilla, H., Halton, E., Bernal, Y., Bouhassira, D. C. G., Arcila, M. E., Gonen, M., Roboz, G. J., Maslak, P., Douer, D., Frattini, M. G., Giralt, S., Sadelain, M., Brentjens, R. Efficacy and Toxicity Management of 19&#8211;28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia Sci. Transl. Med. 2014. 6.</ns2:references>
    <ns2:references>Lieberman, J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal Nat. Rev. Immunol. 2003. 3:361-70.</ns2:references>
    <sbol:version>1</sbol:version>
    <ns1:subject>polyethylenimine</ns1:subject>
    <ns1:subject>small ubiquitin-like modifier (SUMO) ligases</ns1:subject>
    <ns1:subject>CD28</ns1:subject>
    <ns1:subject>carcinoembryonic antigen</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_1_comp/1"/>
    <ns1:subject>small ubiquitin-like modifier 1</ns1:subject>
    <ns1:subject>etch virus protease</ns1:subject>
    <ns1:subject>Cytoplasmic Oncoprotein VErifier and Response Trigger</ns1:subject>
    <ns1:subject>antigen receptors</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_5_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_4_sequence/1"/>
    <ns1:subject>proteases</ns1:subject>
    <ns1:creator>Patrick Ho</ns1:creator>
    <ns1:subject>H9</ns1:subject>
    <ns1:subject>lines</ns1:subject>
    <ns2:references>Wu, A. M., Senter, P. D. Arming antibodies: prospects and challenges for immunoconjugates Nat. Biotechnol. 2005. 23:1137-1146.</ns2:references>
    <ns1:subject>bovine</ns1:subject>
    <ns1:subject>mammalian cell cultures</ns1:subject>
    <ns1:subject>Raji cells</ns1:subject>
    <ns1:subject>Ac-IEPD</ns1:subject>
    <ns2:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_3_comp/1"/>
    <ns1:subject>epidermal growth factor</ns1:subject>
    <ns2:references>Chen, Y. Y. Efficient Gene Editing in Primary Human T Cells Trends Immunol. 2015. 36:667-669.</ns2:references>
    <ns1:subject>mock</ns1:subject>
    <ns1:subject>-peptide</ns1:subject>
    <ns1:subject>Proteases</ns1:subject>
    <ns1:subject>cells</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_6_comp/1"/>
    <ns3:OBI_0001617>28510446</ns3:OBI_0001617>
    <ns1:subject>sodium butyrate</ns1:subject>
    <ns1:subject>mammalian synthetic biology</ns1:subject>
    <ns1:subject>BW135/80</ns1:subject>
    <ns1:subject>paranitroaniline group</ns1:subject>
    <ns2:references>Collins, D. C., Sundar, R., Lim, J. S. J., Yap, T. A. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics Trends Pharmacol. Sci. 2017. 38:25-40.</ns2:references>
    <ns1:subject>CHAPS</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_11_comp/1"/>
    <ns2:references>Ma, C., Wu, B., Huang, X., Yuan, Z., Nong, K., Dong, B., Bai, Y., Zhu, H., Wang, W., Ai, K. SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9 Tumor Biol. 2014. 35:12729-35.</ns2:references>
    <ns2:rightsHolder>American Chemical Society</ns2:rightsHolder>
    <ns1:subject>red dotted line</ns1:subject>
    <ns1:subject>Raji target cells</ns1:subject>
    <ns1:subject>CD19 CARs</ns1:subject>
    <ns1:subject>GrB</ns1:subject>
    <ns1:subject>Tris</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_2_comp/1"/>
    <ns1:subject>perforin</ns1:subject>
    <ns1:subject>untransfected HEK293T cells</ns1:subject>
    <ns1:subject>TEVp</ns1:subject>
    <ns1:subject>mCherry</ns1:subject>
    <ns1:subject>HEPES</ns1:subject>
    <ns2:references>Imai, K., Takaoka, A. Comparing antibody and small-molecule therapies for cancer Nat. Rev. Cancer 2006. 6:714-727.</ns2:references>
    <ns1:subject>horseradish</ns1:subject>
    <ns2:references>Smyth, M. J., McGuire, M. J., Thia, K. Y. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I J. Immunol. 1995. 154:6299-305.</ns2:references>
    <ns1:subject>F-12K</ns1:subject>
    <ns1:subject>Raji</ns1:subject>
    <ns1:subject>proteases&#58872;with</ns1:subject>
    <ns1:subject>EF1&#945;</ns1:subject>
    <ns1:subject>sentrin-specific proteases</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_8_comp/1"/>
    <ns1:subject>Jurkat cell</ns1:subject>
    <ns1:subject>T2A</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_12_comp/1"/>
    <ns1:subject>Lines HEK293T</ns1:subject>
    <ns2:references>Rosenberg, S. A. Finding suitable targets is the major obstacle to cancer gene therapy Cancer Gene Ther. 2014. 21:45-7.</ns2:references>
    <ns2:references>Trapani, J. A., Browne, K. A., Dawson, M., Smyth, M. J. Immunopurification of Functional Asp-ase (Natural Killer Cell Granzyme B) Using a Monoclonal Antibody Biochem. Biophys. Res. Commun. 1993. 195:910-920.</ns2:references>
    <ns1:subject>sucrose</ns1:subject>
    <ns1:subject>PC-3</ns1:subject>
    <ns1:subject>Cell Line</ns1:subject>
    <ns1:subject>enterokinase</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_8_sequence/1"/>
    <ns1:subject>CEA</ns1:subject>
    <ns1:subject>oligonucleotides</ns1:subject>
    <ns1:rights>Copyright &amp; 2017 American Chemical Society</ns1:rights>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_12_sequence/1"/>
    <ns1:subject>nitrogen</ns1:subject>
    <ns1:subject>CD19</ns1:subject>
    <ns1:subject>Glu-Asn-Leu-Tyr-Phe-Gln-Gly</ns1:subject>
    <ns2:references>Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., Mahnke, Y. D., Melenhorst, J. J., Rheingold, S. R., Shen, A., Teachey, D. T., Levine, B. L., June, C. H., Porter, D. L., Grupp, S. A. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia N. Engl. J. Med. 2014. 371:1507-1517.</ns2:references>
    <ns1:subject>Human</ns1:subject>
    <ns2:references>Ewen, C., Kane, K. P., Shostak, I., Griebel, P. J., Bertram, E. M., Watts, T. H., Bleackley, R. C., McElhaney, J. E. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B J. Immunol. Methods 2003. 276:89-101.</ns2:references>
    <ns1:subject>granzymes</ns1:subject>
    <ns1:subject>Asp-Asp-Asp-Asp-Lys</ns1:subject>
    <ns2:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <ns1:subject>Jurkat E6</ns1:subject>
    <ns1:subject>EGFP</ns1:subject>
    <ns1:subject>tobacco</ns1:subject>
    <ns2:references>Mattoscio, D., Chiocca, S. SUMO pathway components as possible cancer biomarkers Future Oncol. 2015. 11:1599-1610.</ns2:references>
    <ns1:subject>SENPs</ns1:subject>
    <ns2:references>Cheng, J., Bawa, T., Lee, P., Gong, L., Yeh, E. T. H. Role of desumoylation in the development of prostate cancer Neoplasia 2006. 8:667-76.</ns2:references>
    <ns1:subject>cathepsin C</ns1:subject>
    <ns1:subject>Billierica</ns1:subject>
    <ns1:subject>HEK293T cells</ns1:subject>
    <ns1:subject>granzyme B</ns1:subject>
    <ns2:references>Voskoboinik, I., Dunstone, M. A., Baran, K., Whisstock, J. C., Trapani, J. A. Perforin: structure, function, and role in human immunopathology Immunol. Rev. 2010. 235:35-54.</ns2:references>
    <ns1:subject>Annexin V</ns1:subject>
    <ns1:subject>protein TagBFP</ns1:subject>
    <ns1:subject>His57</ns1:subject>
    <ns1:subject>Phenol</ns1:subject>
    <ns2:created>2017-05-16</ns2:created>
    <ns1:subject>RWPE-1</ns1:subject>
    <ns1:subject>TagBFP</ns1:subject>
    <ns2:references>Morgan, R. A., Yang, J. C., Kitano, M., Dudley, M. E., Laurencot, C. M., Rosenberg, S. A. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 Mol. Ther. 2010. 18:843-51.</ns2:references>
    <ns1:subject>CD19 CAR</ns1:subject>
    <ns1:subject>N-acetyl-Ile-Glu-Pro-Asp-paranitroanilide</ns1:subject>
    <ns2:references>Trapani, J. A. Granzymes: a family of lymphocyte granule serine proteases Genome Biol. 2001. 2.</ns2:references>
    <ns1:subject>P1-Gln</ns1:subject>
    <ns1:subject>SENP1</ns1:subject>
    <ns2:references>Wang, G., Yang, L., Grishin, D., Rios, X., Ye, L. Y., Hu, Y., Li, K., Zhang, D., Church, G. M., Pu, W. T. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies Nat. Protoc. 2017. 12:88-103.</ns2:references>
    <ns1:creator>Yvonne Y. Chen</ns1:creator>
    <ns2:references>Andrade, F., Roy, S., Nicholson, D., Thornberry, N., Rosen, A., Casciola-Rosen, L. Granzyme B Directly and Efficiently Cleaves Several Downstream Caspase Substrates: Implications for CTL-Induced Apoptosis Immunity 1998. 8:451-460.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_3_sequence/1"/>
    <ns2:references>Kolli, N., Mikolajczyk, J., Drag, M., Mukhopadhyay, D., Moffatt, N., Dasso, M., Salvesen, G., Wilkinson, K. D. Distribution and paralogue specificity of mammalian deSUMOylating enzymes Biochem. J. 2010. 430:335-44.</ns2:references>
    <ns2:references>Hickey, C. M., Wilson, N. R., Hochstrasser, M. Function and regulation of SUMO proteases Nat. Rev. Mol. Cell Biol. 2012. 13:755-766.</ns2:references>
    <ns1:subject>l-glutamine</ns1:subject>
    <ns1:type>research-article</ns1:type>
    <ns1:subject>rational protein
engineering</ns1:subject>
    <ns2:references>Jacques, C., Baris, O., Prunier-Mirebeau, D., Savagner, F., Rodien, P., Rohmer, V., Franc, B., Guyetant, S., Malthiery, Y., Reynier, P. Two-Step Differential Expression Analysis Reveals a New Set of Genes Involved in Thyroid Oncocytic Tumors J. Clin. Endocrinol. Metab. 2005. 90:2314-2320.</ns2:references>
    <ns1:subject>Ac-IEPD-</ns1:subject>
    <ns1:subject>Asp194</ns1:subject>
    <ns1:subject>human</ns1:subject>
    <ns1:subject>CARs</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_11_sequence/1"/>
    <ns2:references>Bawa-Khalfe, T., Yeh, E. T. H. SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression Genes Cancer 2010. 1:748-752.</ns2:references>
    <ns1:subject>RPMI-</ns1:subject>
    <sbol:persistentIdentity rdf:resource="http://examples.org/sb6b00392"/>
    <ns3:OBI_0002110 rdf:resource="https://doi.org/10.1021/acssynbio.6b00392"/>
    <ns1:subject>2A peptide</ns1:subject>
    <ns2:references>Wang, X., Popplewell, L. L., Wagner, J. R., Naranjo, A., Blanchard, M. S., Mott, M. R., Norris, A. P., Wong, C. W., Urak, R. Z., Chang, W.-C., Khaled, S. K., Siddiqi, T., Budde, L. E., Xu, J., Chang, B., Gidwaney, N., Thomas, S. H., Cooper, L. J. N., Riddell, S. R., Brown, C. E., Jensen, M. C., Forman, S. J. Phase 1 studies of central memory&#8211;derived CD19 CAR T&#8211;cell therapy following autologous HSCT in patients with B-cell NHL Blood 2016. 127:2980-2990.</ns2:references>
    <ns2:references>Duong, C. P. M., Yong, C. S. M., Kershaw, M. H., Slaney, C. Y., Darcy, P. K. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic Mol. Immunol. 2015. 67:46-57.</ns2:references>
    <ns1:subject>Ile16</ns1:subject>
    <ns1:subject>CD3</ns1:subject>
    <ns1:subject>Production</ns1:subject>
    <ns1:subject>mock-transfected HEK293T lysates</ns1:subject>
    <ns1:subject>imidazole</ns1:subject>
    <ns1:subject>NaCl</ns1:subject>
    <ns2:references>Desjardins, L. M., MacManus, J. P. An Adherent Cell Model to Study Different Stages of Apoptosis Exp. Cell Res. 1995. 216:380-387.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_1_sequence/1"/>
    <ns1:subject>Ni 2+ -Affinity Protein Purification HEK293T cells</ns1:subject>
    <ns1:subject>H9 cells</ns1:subject>
    <ns1:subject>SUMO</ns1:subject>
    <ns1:subject>glycerol</ns1:subject>
    <ns2:references>Zhang, J., Yang, P. L., Gray, N. S. Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 2009. 9:28-39.</ns2:references>
    <ns2:references>Dustin, M. L., Long, E. O. Cytotoxic immunological synapses Immunol. Rev. 2010. 235:24-34.</ns2:references>
    <ns1:subject>IL-15</ns1:subject>
    <ns1:subject>HRP</ns1:subject>
    <ns1:subject>transfected</ns1:subject>
    <ns2:references>Yam, P., Li, S., Wu, J., Hu, J., Zaia, J. A., Yee, J.-K. Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells Mol. Ther. 2002. 5:479-484.</ns2:references>
    <ns1:subject>expressing cells</ns1:subject>
    <ns2:references>Adams, G. P., Weiner, L. M. Monoclonal antibody therapy of cancer Nat. Biotechnol. 2005. 23:1147-1157.</ns2:references>
    <ns1:subject>cell line</ns1:subject>
    <ns2:references>Rosenblum, M. G., Barth, S. Development of novel, highly cytotoxic fusion constructs containing granzyme B: unique mechanisms and functions Curr. Pharm. Des. 2009. 15:2676-92.</ns2:references>
    <ns1:subject>targeted therapy</ns1:subject>
    <ns1:subject>platform&#58872;termed Cytoplasmic Oncoprotein VErifier and Response Trigger</ns1:subject>
    <ns2:dateCopyrighted>2017</ns2:dateCopyrighted>
    <ns2:isPartOf>ACS Synthetic Biology</ns2:isPartOf>
    <ns1:subject>Gly residue</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_7_comp/1"/>
    <sbol:displayId>sb6b00392</sbol:displayId>
    <ns1:creator>Christopher Ede</ns1:creator>
    <ns1:subject>transiently</ns1:subject>
    <ns1:subject>dipeptidyl peptidase cathepsin C</ns1:subject>
    <ns2:references>Kapust, R. B., To&#776;zse&#769;r, J., Copeland, T. D., Waugh, D. S. The P1&#8242; specificity of tobacco etch virus protease Biochem. Biophys. Res. Commun. 2002. 294:949-955.</ns2:references>
    <ns2:references>Garraway, L. A. Genomics-driven oncology: framework for an emerging paradigm J. Clin. Oncol. 2013. 31:1806-14.</ns2:references>
    <ns1:subject>HEK293T</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_4_comp/1"/>
    <ns1:subject>Triton-X</ns1:subject>
    <ns2:references>Dall, P., Heider, K.-H., Sinn, H.-P., Skroch-Angel, P., Adolf, G., Kaufmann, M., Herrlich, P., Ponta, H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer Int. J. Cancer 1995. 60:471-477.</ns2:references>
    <ns2:description>Targeted therapies promise to increase the safety and efficacy of treatments against diseases ranging from cancer to viral infections. However, the vast majority of targeted therapeutics relies on the recognition of extracellular biomarkers, which are rarely restricted to diseased cells and are thus prone to severe and sometimes-fatal off-target toxicities. In contrast, intracellular antigens present a diverse yet underutilized repertoire of disease markers. Here, we report a protein-based therapeutic platform&#58872;termed Cytoplasmic Oncoprotein VErifier and Response Trigger (COVERT)&#58872;which enables the interrogation of intracellular proteases to trigger targeted cytotoxicity. COVERT molecules consist of the cytotoxic protein granzyme B (GrB) fused to an inhibitory N-terminal peptide, which can be removed by researcher-specified proteases to activate GrB function. We demonstrate that fusion of a small ubiquitin-like modifier 1 (SUMO1) protein to GrB yields a SUMO-GrB molecule that is specifically activated by the cancer-associated sentrin-specific protease 1 (SENP1). SUMO-GrB selectively triggers apoptotic phenotypes in HEK293T cells that overexpress SENP1, and it is highly sensitive to different SENP1 levels across cell lines. We further demonstrate the rational design of additional COVERT molecules responsive to enterokinase (EK) and tobacco etch virus protease (TEVp), highlighting the COVERT platform&#8217;s modularity and adaptability to diverse protease targets. As an initial step toward engineering COVERT-T cells for adoptive T-cell therapy, we verified that primary human T cells can express, package, traffic, and deliver engineered GrB molecules in response to antigen stimulation. Our findings set the foundation for future intracellular-antigen-responsive therapeutics that can complement surface-targeted therapies.</ns2:description>
    <ns2:dateSubmitted>2016-12-26</ns2:dateSubmitted>
    <ns1:subject>DTT</ns1:subject>
    <ns1:subject>protease</ns1:subject>
    <ns2:references>Pinkoski, M. J., Hobman, M., Heibein, J. A., Tomaselli, K., Li, F., Seth, P., Froelich, C. J., Bleackley, R. C. Entry and Trafficking of Granzyme B in Target Cells During Granzyme B-Perforin&#8211;Mediated Apoptosis Blood 1998. 92:1044-1054.</ns2:references>
    <ns2:references>Da&#776;lken, B., Giesu&#776;bel, U., Knauer, S. K., Wels, W. S. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition Cell Death Differ. 2006. 13:576-85.</ns2:references>
    <ns1:subject>Pico</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00392_9_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00392_7_sequence/1"/>
    <ns1:subject>adoptive T-cell
therapy</ns1:subject>
    <ns1:subject>ENLYFQ</ns1:subject>
    <ns1:subject>&#8242;-Gly</ns1:subject>
    <ns2:references>Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W. C., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., Futreal, P. A. Mutations of the BRAF gene in human cancer Nature 2002. 417:949-54.</ns2:references>
    <ns1:subject>propeptide</ns1:subject>
    <ns2:references>Bond, J. S., Butler, P. E. Intracellular Proteases Annu. Rev. Biochem. 1987. 56:333-64.</ns2:references>
    <ns1:subject>trypsin</ns1:subject>
    <ns2:abstract>Targeted therapies promise to increase the safety and efficacy of treatments against diseases ranging from cancer to viral infections. However, the vast majority of targeted therapeutics relies on the recognition of extracellular biomarkers, which are rarely restricted to diseased cells and are thus prone to severe and sometimes-fatal off-target toxicities. In contrast, intracellular antigens present a diverse yet underutilized repertoire of disease markers. Here, we report a protein-based therapeutic platform&#58872;termed Cytoplasmic Oncoprotein VErifier and Response Trigger (COVERT)&#58872;which enables the interrogation of intracellular proteases to trigger targeted cytotoxicity. COVERT molecules consist of the cytotoxic protein granzyme B (GrB) fused to an inhibitory N-terminal peptide, which can be removed by researcher-specified proteases to activate GrB function. We demonstrate that fusion of a small ubiquitin-like modifier 1 (SUMO1) protein to GrB yields a SUMO-GrB molecule that is specifically activated by the cancer-associated sentrin-specific protease 1 (SENP1). SUMO-GrB selectively triggers apoptotic phenotypes in HEK293T cells that overexpress SENP1, and it is highly sensitive to different SENP1 levels across cell lines. We further demonstrate the rational design of additional COVERT molecules responsive to enterokinase (EK) and tobacco etch virus protease (TEVp), highlighting the COVERT platform&#8217;s modularity and adaptability to diverse protease targets. As an initial step toward engineering COVERT-T cells for adoptive T-cell therapy, we verified that primary human T cells can express, package, traffic, and deliver engineered GrB molecules in response to antigen stimulation. Our findings set the foundation for future intracellular-antigen-responsive therapeutics that can complement surface-targeted therapies.</ns2:abstract>
  </sbol:Collection>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_10_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_10_sequence"/>
    <sbol:displayId>sb6b00392_10_sequence</sbol:displayId>
    <sbol:elements>gccgccaccatgcagcccatcctgctccttctggccttcctgctgctgcccagggccgacgccgaaaacctgtacttccaaatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctccta</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00392_6_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb6b00392_6_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00392_6_sequence"/>
    <sbol:elements>gccgccaccatgcagcccatcctgctccttctggccttcctgctgctgcccagggccgacgccatcatcgggggacatgaggccaagccccactcccgcccctacatggcttatcttatgatctgggatcagaagtctctgaagaggtgcggtggcttcctgatacaagacgacttcgtgctgacagctgctcactgttggggaagctccataaatgtcaccttgggggcccacaatatcaaggaacaggagccgacccagcagtttatccctgtgaaaagacccatcccccatccagcctataatcctaagaacttctccaatgacatcatgctactgcagctggagagaaaggccaagcggaccagagctgtgcagcccctcaggctacctagcaacaaggcccaggtgaagccagggcagacatgcagtgtggccggctgggggcagacggcccccctgggaaaacactcacacacactacaagaggtgaagatgacagtgcaggaagatcgaaagtgcgaatctgacttacgccattattacgacagtaccattgagttgtgcgtgggggacccagagattaaaaagacttcctttaagggggactctggaggccctcttgtgtgtaacaaggtggcccagggcattgtctcctatggacgaaacaatggcatgcctccacgagcctgcaccaaagtctcaagctttgtacactggataaagaaaaccatgaaacgctactaa</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
</rdf:RDF>
